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Abstract
Introduction
Carbon monoxide (CO) poisoning is frequent worldwide but knowledge regarding the epide-
miology is insufficient. The aim of this study was to clarify the extent of this intoxication, its
mortality and factors associated with mortality.
Materials and methods
National databases from Statistics Denmark were used to identify individuals who suffered
from CO-poisoning during 1995–2015, as well as information regarding co-morbidities, mor-
tality and manner of death.
Results
During the period from 1995 to 2015, 22,930 patients suffered from CO-poisoning in Den-
mark, and 21,138 of these patients (92%) were hospitalized. A total of 2,102 patients died
within the first 30 days after poisoning (9.2%). Among these, 1,792 (85% of 2,102) were
declared dead at the scene and 310 (15% of 2,102) died during hospitalization. Deaths due
to CO-poisoning from smoke were intentional in 6.3% of cases, whereas deaths due to CO
containing gases were intentional in 98.0% of cases. Among patients who survived >30
days, there was no significant difference in survival when comparing hyperbaric oxygen
therapy (HBO) treatment with no HBO treatment after adjustment for age and co-morbidities
such as drug abuse, psychiatric disease, stroke, alcohol abuse, arterial embolism, chronic
obstructive pulmonary disease, cerebrovascular disease and atrial fibrillation. Several co-
morbidities predicted poorer outcomes for patients who survived the initial 30 days.
Conclusions
Poisoning from smoke and/or CO is a frequent incident in Denmark accounting for numer-
ous contacts with hospitals and deaths. Both intoxication and mortality are highly associated
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with co-morbidities interfering with cognitive and physical function. Treatment with HBO was
not seen to have an effect on survival.
Introduction
Since carbon monoxide (CO) has no smell, no taste and no color, it is very hard to detect with-
out the use of a CO-detector. This stealthiness, along with its highly toxic properties, makes it
extremely dangerous, and victims might not suspect any danger until they are incapacitated
and need help to survive.
Persisting or late onset of neurological symptoms frequently contribute to morbidity [1–2],
but arrhythmias and cardiac insufficiency are also reported following CO-poisoning [3–4].
Previously, town gas containing CO used for residential heating and CO in car exhaust
were prominent causes of CO-poisoning. However, since CO has been removed from town
gas in Europe and cars are equipped with catalytic converters, the number of cases has
dropped markedly [5–7]. Today, smoke from fires, indoor charcoal burning, defective domes-
tic heat sources and suicide/suicide attempts are frequent causes of CO-poisoning [8].
Different harmful mechanisms contribute to the high level of toxicity. Most commonly
known is the strong binding to hemoglobin facilitated by the high affinity for the iron ions in
this molecule [9]. The oxygen-carrying capacity is thus diminished, leading to universally
impaired oxygen delivery. However, CO also interferes with mitochondrial enzyme activity,
inhibiting aerobic metabolism [10]. Additionally, several other toxic effects occur [8]
Treatment of CO-poisoning has not evolved much during the last 50 years. It primarily
consists of supplementary oxygen therapy and symptomatic treatment. Normobaric (NBO) or
hyperbaric (HBO) oxygen can be administered in a pressurized chamber which is usually
reserved for more severe cases. However, some patients may be too unstable to transfer to an
HBO-capable center.
Although it is well documented that HBO therapy can reduce the HbCO half-life [11], the
advantages of HBO therapy are still questioned due to a lack of decisive evidence of improved
survival and reduced morbidity [9,12–15].
In 2003, an updated report from the Danish Health Institute collected data on all CO-poi-
soning cases from 1997–2001 [16]. A total of 3,671 cases were identified. This report was used
for national guideline purposes only. Overall, no comprehensive epidemiological studies of
CO poisoning in Denmark exist. The aim of this study was to clarify the extent of this intoxica-
tion, its mortality and factors contributing to mortality.
Material and methods
The study was accepted by the Data Protection Agency (GEH-2014-013 I-Suite nr: 02731) and
it is a retrospective nationwide cohort study. All citizens in Denmark are equipped with a
unique personal identification number (CPR number), which is registered in all contacts with
the health care system. Settlement of the correct rate of reimbursement is based on the correct
registration of both CPR number and diagnoses. According to current legislation in Denmark,
it is not necessary to obtain approval by the individual patient or general ethics approval for
register-based studies. All contacts are registered in various databases administered by Statis-
tics Denmark. These databases can be accessed for health management purposes and epidemi-
ological research. The CPR number is encrypted in the same way across databases, which
enables cross-referencing without accessing personally identifiable information. Data were
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accessed using encrypted remote access to Statistic Denmark´s servers. Three different data-
bases managed by Statistics Denmark were used. The Danish National Patient Register
(DNPR) has registered all hospital admissions and discharge coding diagnoses in Denmark
since 1978. Diagnoses and procedures are coded according to the International Classification
of Diseases (8th revision (ICD-8) through the end of 1993, and 10th revision (ICD-10) thereaf-
ter) [17]. Since 1875, the the Danish Register of Causes of Death has registered all deaths and
cause(s) of deaths among citizens that died in Denmark. Registration has been in accordance
with WHO’s rules since 1994 by ICD-10 [18] and The National Prescription Registry which
contains information regarding all claimed prescriptions since 1994, including date of dispen-
sation, strength and quantity. This database has been proven to contain valid information
regarding the use of medication in Denmark [19].
Data from 01.01.1995 to 31.12.2015 were included in this study. We chose 01.01.1995 as the
cut-off day beacause ICD coding prior to this date was different.
From the DNPR, all patients in contact with emergency departments or admitted to a hos-
pital with the International Statistical Classification of Diseases and Related Health Problems
codes (ICD-10) T58; toxic effect of carbon monoxide, and T59; Toxic effect of other gases,
fumes and vapors were identified. Patients with the following irrelevant intoxications were
excluded: T590; nitrogen oxides, DT591; sulfur dioxide, T592; formaldehyde, T593; lacrimo-
genic gas, T594; chlorine gas, T595; fluorine gas and hydrogen fluoride, T596; hydrogen sul-
fide, and T597; CO2. Co-morbidities identified in the DNPR were drug abuse, psychiatric
disease, stroke, alcohol abuse, heart failure, renal failure, arterial embolism, chronic obstructive
pulmonary disease (COPD), myocardial infarction, cerebrovascular disease, atrial fibrillation,
and all types of dementia. Information regarding the identification of patients suffering from
diabetes mellitus was extracted from The National Prescription Registry using insulin drugs as
a marker (ATC code A10A).
Only patients who had contact with emergency departments or were admitted to hospitals
are represented in the DNPR. To identify those patients who were declared dead at the scene
the Danish Register of Causes of Death was used with the same ICD-10 criteria.
Statistical analysis
We used the chi-square test to compare variables for patients admitted to the hospital versus
patients who died at the scene and to evaluate differences between patients who received HBO
and those who did not. For age, we used independent sample t-tests. A linear regression model
was used to predict any trends in the number of deaths.
To minimize the effects of selection bias in our survival analysis, we used data from patients
who survived for at least 30 days after poisoning in our models. To evaluate survival among
patients who reached a hospital, Kaplan-Meier estimates were used, comparing the survival of
patients not treated with HBO to that of patients treated with HBO. The overall difference was
estimated using the log-rank test. To evaluate the effect of various co-morbidities, a Cox
regression model was constructed using only data from patients who survived beyond the first
30 days after CO-poisoning. The Results are presented as hazard ratios (HR) with correspond-
ing confidence intervals (CI). We tested for any violation of the proportional hazards assump-
tion using Schoenfeld residuals. Age was divided into four subgroups equivalent to the
quantiles: age group 1 = 0–24.4 years, age group 2 = 24.4–36.6 years, age group 3 = 36.6–50.75
years, and age group 4 = 50.8+ years. Age group 2 was used as a reference in the model.
For data management, the software SAS (version 9.4, SAS Institute, Cary, North Carolina,
USA) was used. For all of the statistical analyses, the open source freeware program R was used
(version 3.4.1).
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Results
A total of 22,930 patients suffered from CO-poisoning from 1995–2015 in Denmark (Fig 1). A
total of 2,102(9.2%) patients died within the first 30 days after CO-poisoning directly or with
CO-poisoning as a contributing cause of death. Out of this group, 1,792 (85.3%) patients were
declared dead at the scene and thus never reached a hospital. Of the 21,138 patients who were
hospitalized or in contact with an emergency department 310(1.5%) died within 30 days.
Autopsies were performed in 40.0% of deaths after 2002. No data prior to 2002 were available.
The median follow-up time in this study was 8.1 years.
Demographic characteristics of patients hospitalized with CO-poisoning and patients who
died elsewhere are presented in Table 1. The mean age of the victims who died at the scene
was 52.6 years (95% confidence interval (CI): 51.7–53.4 years) vs. 39.3 years (95% (CI): 39.0–
39.6 years) for the hospitalized patients (p<0.001). The majority of victims were males, espe-
cially among those who did not reach a hospital (77.4%). Further comparisons of victims who
died on scene vs. those who reached hospital alive revealed a larger proportion of patients who
were diagnosed with alcohol abuse (21.8% vs. 12.2%, p<0.001), drug abuse (17.4% vs. 10.3%,
p<0.001) and psychiatric disease (12.9% vs. 8.3%, p<0.001).
Co-morbidities among initial surviving patients receiving HBO therapy (n = 431) were dif-
ferent from those who did not receive HBO therapy (Table 1). The mean age in the HBO group
was higher (45.2 years vs. 39.1 years, p<0.001), and there was a higher 30-day mortality rate
(11.1% vs. 1.3%, p<0.001). A higher proportion of patients in the HBO group had been diag-
nosed with alcohol abuse (20.9% vs. 12.0%, p<0.001), drug abuse (19.0% vs. 10.1%, p<0.001)
and psychiatric disease (16.2% vs. 8.1%, p<0.001). A greater proportion were males in both the
HBO group (59.1%) and in the no HBO group (63.6%) and the difference between these groups
was significant (p<0.001). Out of 825 deaths due to CO-containing smoke from fire/flames, 718
were accidental (87.0%), 52 were intentional (7.2%) and 55 were undetermined (6.7%) (Fig 2).
Out of 1,132 deaths due to gas/vapors, 94 were accidental (8.3%), 1,025 were intentional
(91.1%) and 13 were undetermined intent (1.1%). A total of 137 died of other forms of CO-
exposure with undetermined manner of death. There was a significant trend over time towards
a decreasing number of deaths due to CO-poisoning (R2 = 0.49, p<0.001) (Fig 3).
Fig 1. Overview of the total rate of cases and the rate of deaths by year. Total number of cases = 22,930.
https://doi.org/10.1371/journal.pone.0210767.g001
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A Kaplan-Meier plot illustrates the survival of hospitalized patients who survived >30 days
(Fig 4). This plot demonstrates diverging survival lines with inferior survival among patients
treated with HBO (p<0.001). Significant differences were observed already 6 years. After
adjustment for co-morbidities in a Cox regression model, HBO treatment was not indepen-
dently associated with increased mortality (HR = 1.2, p = 0.14) (Fig 5). Age was significantly
associated with the risk of mortality. The HR increased with increasing age; age group 3 had
an HR = 3.2, p<0.001, and age group 4 had an HR = 15.5, p<0.001. Other factors associated
with increased mortality were alcohol abuse (HR = 2.1, p<0.001), psychiatric disease (HR =
1.5, p<0.001), arterial embolism (HR = 1.5, p = 0.01), COPD (HR = 1.7, p<0.001), cerebrovas-
cular disease (HR = 1.5, p<0.001) and atrial fibrillation (AF) (HR = 2.3, p<0.001). Drug abuse
(HR = 1.1, p = 0.35), stroke (HR = 1.1, p = 0.40), and gender (HR = 0.96, p = 0.32) were not sig-
nificant predictors of mortality.
Discussion
This study shows that HBO treatment was not associated with survival benefit compared with
that of no HBO treatment after adjustment for several confounding factors. It also demon-
strated that a large percentage of CO-poisoned victims had a history of psychiatric diseases
and alcohol abuse. These co-morbidities, along with increasing age, were strongly associated
with mortality. Approximately, 50% of deaths were intentional; however, a higher proportion
of deaths caused by CO-poisoning from gas were intentional compared to intentional deaths
due to poisoning from smoke from fire.
There is a strong association between suicide and psychiatric disease as well as between sui-
cide and the abuse of alcohol and drugs [20–21]. This is clearly reflected in our study as a large
Table 1. Overview of sex, age and co-morbidities in various subgroups of the study population.
Variable Group Treatment
Dead at Scene Hospitalized p-value No HBO HBO p-value
Mean age (SD) 52.6 (18.9) 39.3 (20.2) < 0.001 39.1 (20.2) 45.2 (21.1) < 0.001
Sex 1387(77.4) 12503(59.1) <0.001 12229(59.1) 274(63.6) < 0.001
30 days Mortality 1792(100.0) 310(1.5) < 0.001 262(1.3) 48(11.1) < 0.001
Drug Abuse 312(17.4) 2169(10.3) < 0.001 2087(10.1) 82(19.0) < 0.001
Alcohol Abuse 391(21.8) 2585(12.2) < 0.001 2495(12.0) 90(20.9) < 0.001
Psychiatric Disease 232(12.9) 1747(8.3) < 0.001 1677(8.1) 70(16.2) < 0.001
Stroke 92(5.1) 701(3.3) < 0.001 675(3.3) 26(6.0) <0.01
Heart Failure 55(3.1) 402(1.9) < 0.001 395(1.9) 7(1.6) 0.8
Renal Failure 15(0.8) 71(0.3) <0.01 66(0.3) 5(1.2) <0.01
Arterial Embolism 110(6.1) 819(3.9) < 0.001 790(3.8) 29(6.7) <0.01
COPD 92(5.1) 643(3.0) < 0.001 630(3.0) 13(3.0) 1.00
Myocardial Infarction 62(3.5) 433(2.0) < 0.001 427(2.1) 6(1.4) 0.42
Cerebrovascular Disease 47(2.6) 365(1.7) <0.01 347(1.7) 18(4.2) < 0.001
Atrial Fibrillation 56(3.1) 422(2.0) <0.01 405(2.0) 17(3.9) <0.01
Other Dementia 16(0.9) 137(0.6) 0.28 131(0.6) 6(1.4) 0.10
Sclerosis 6(0.3) 44(0.2) 0.40 44(0.2) 0 0.67
Pulmonary Embolism 7(0.4) 40(0.2) 0.12 39(0.2) - -
Peripheral Arterial Disease 54(3.0) 203(1.0) < 0.001 199(1.0) - -
Those who died at the scene vs. those where hospitalized (second column). In hospitalized patients; those who were treated with hyperbaric oxygen (HBO) therapy vs.
those who were not (third column). COPD = chronic obstructive pulmonary disease.
https://doi.org/10.1371/journal.pone.0210767.t001
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proportion of deaths from CO-poisonings were suicides (51%), and a substantial number of
patients had psychiatric disease or, abused alcohol and drugs (Table 1). Among contributing
factors, victims may have a higher risk of exposure to CO-poisoning since impaired cognitive
function can cause unsafe behavior in connection with potential sources of CO, e.g., fire and
gas installations. It is also plausible that in cases of accidental exposure, this group may not be
as capable of escaping outside as quickly as other poisoning victims, resulting in increased
Fig 2. Number of fatalities by type of exposure and manner of death.
https://doi.org/10.1371/journal.pone.0210767.g002
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severity of intoxication. These effects could also be the case for older victims and victims with
a prior history of cerebrovascular disease, stroke and AF. The co-morbidities may also explain
why the average lifespan after CO-poisoning seems to be reduced (Fig 4) when compared to
the general life expectancy in Denmark, which is approximately 80 years. These findings are
consistent with a previous study that showed increased long-term mortality among survivors
of acute CO-poisoning who received HBO treatment [22].
There was a significant difference in long-term survival among patients receiving treatment
with HBO therapy versus no HBO therapy in our survival analysis (p>0.001). These findings
are also consistent with the results of the above-mentioned study by Hampson et al. [22]. In
Fig 3. Trend in the number of fatal cases. The grey area depicts 95% CI, p<0.001.
https://doi.org/10.1371/journal.pone.0210767.g003
Fig 4. Kaplan-Meier plot of survival depending on treatment. Only those who lived beyond 30 days are included.
Light blue-/red-colored areas depicts 95% CI.
https://doi.org/10.1371/journal.pone.0210767.g004
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our study, HBO treatment was not an independent predictor of mortality after adjustments in
the Cox regression model. The difference in long-term survival is therefore not caused by
HBO therapy itself. One plausible explanation could be the significant difference in the burden
of comorbidities between the groups.
The overall 30-day mortality was relatively high (9.2%), including those who died at the
scene. However, among those who arrived at the hospital, the 30-day mortality was only 1.5%.
This difference may be explained by the fact that a large proportion of CO victims were
declared dead at the scene and therefore did not contribute to the in-hospital 30-day mortality.
It may also be speculated that a person trying to commit suicide from CO poisoning will be
discovered later, in a more poisoned condition or dead, than those who become intoxicated by
accident. Furthermore, transportation to the hospital may be a marker for a patient with an
inherently better prognosis. A number of factors may contribute to selection bias of the
patients receiving HBO therapy. There is no international consensus regarding the criteria for
treatment with HBO therapy [23]. In Denmark, HBO therapy is primarily performed at a sin-
gle hospital (Rigshospitalet, Copenhagen) although a hyperbaric chamber also exists at one
other university hospital. The referral criteria for hyperbaric oxygen (HBO) therapy in Den-
mark are neurological abnormities that are more severe than normal head-aches, present or
previous loss of consciousness, cardiac arrhythmias/depression, pregnancy and carboxyhemo-
globin (HbCO) more than 25%, regardless of other symptoms [24]. The criteria for HBO ther-
apy in Denmark tend to select patients with a higher degree of severity, while logistic issues
with transportation of critically ill patients from other parts of Denmark may tend to exclude
some of the most severe cases. Additionally, it should be noted that the vast majority of
patients who died, had no opportunity for receiving HBO treatment, as they were declared
dead on scene. By looking only at the patients who survived >30 days after admission, we can
eliminate some of this bias. However, to evaluate the true difference between HBO versus
NBO therapies, more prospective randomized studies are required, as previous studies of this
character have not sufficiently uncovered the role of HBO therapy [13].
It is interesting to note that the percentage of patients receiving HBO therapy was less than
2%; it has been reported that this treatment was offered to a higher percentage of patients in
Taiwan [14]. This difference may be explained by differences regarding access to hospitals for
patients with only minor CO-poisoning. The differences regarding access to HBO treatment
may explain differences in survival among studies.
Only a few Danish epidemiologic studies regarding CO-poisoning exist, and most of these
studies have a forensic focus. In a paper from 1960, Dalgaard examined deaths related to town
gas [5] and identified a total of 407 cases (299 suicides, 90 accidents, 18 homicides). This study
did not include other cases of CO-poisoning. In 2007, Thomsen and Gregersen investigated
Fig 5. Forest plot for the Cox proportional hazards model. Age group 1 = 0–24.4 years, age group 2 (reference) =
24.4–36.6 years, age group 3 = 36.6–50.75 years, and age group 4 = 50.8+ years. COPD = Chronic Obstructive
Pulmonary Disease. Lines illustrate 95% CI.
https://doi.org/10.1371/journal.pone.0210767.g005
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CO-related deaths from 1995–1999 and found that 22 cases of town gas exposure resulted in
death out of a total of 449 non- fire related CO-poisoning cases [6]. However, these studies are
not representative of the current conditions because town gas was phased out from 1989–
2007. Another study by Thomsen and Gregersen published in 2005 [7] looked at all suicides
caused by CO-poisoning from car exhaust gas from 1995–1999. A total of 388 cases were iden-
tified, constituting 9.3% of all suicides in Denmark during that period. The catalytic converter
has been mandatory in all new vehicles sold in Denmark since 1990. However, since this only
applied to new cars at that time, the real implementation has been over a period of 10–20
years. This probably plays a role in the decrease in the number of CO-poisoning cases in the
period from 1987–1999 and could be a result of an increased number of cars operating with
catalytic converters [7]. This is supported by a study by Hampson and Holm from 2015 [25].
The authors compared CO emission data with cases of CO poisoning. They concluded that
there was a strong association between the reduction in vehicle exhaust CO emissions and the
decreasing numbers of CO poisoning cases from 1985—this is likely to be a result of the intro-
duction of the catalytic converters in 1975.
In an American study from 2007, the total number of emergency department visits due to
CO-poisoning was estimated to be approximately 50,000 annually [26]. The authors reached
this number by extrapolating data from 2005 from five states. This was equivalent to 16 cases
of CO-poisoning per 100,000 inhabitants/year. The corresponding number of cases in 2005 in
the present study was 19/100,000 per year. These similar incidences probably reflect the com-
parable daily living conditions in western countries and comparable methods of registration.
Another American paper from 2016 identified the number of deaths from CO-poisoning by
using national data from death certificates [27]. The number of fatalities in the US in 2005 was
1,702 with a significant trend for a decreasing number of deaths from 1999 to 2014. These find-
ings are in agreement with the results of the present study.
In a paper published in 2012 [28], the authors gained information regarding CO-poisoning
and the associated mortality from 28 European WHO member states. During the period from
1980 to 2008, they reported 140,490 CO-related deaths in total, with a death rate of 2.2 per
100,000 people annually. However, the range was between 0.02 and 12.8 depending on the
country. Six countries provided additional data regarding admissions due to CO-poisoning,
with a total of 31,473 admissions. The mean rate of admissions was 2.33 per 100,000 people/
year. This paper identified males as more prone to suffer from CO-poisoning and established
age as a predictor of increased mortality. These findings are consistent with the findings in the
present study. In contrast with the findings of the present study other studies suggest that
HBO therapy is associated with lower short- and long-term mortality [12,14]. The reason for
this difference may be differences in treatment indication, differences in logistics and differ-
ences regarding patient population and database registrations. The primary strength of the
present study is the completeness of data from validated databases. Furthermore, Denmark is a
small country with a high degree of homogeneity in the population as well as in health care ser-
vices, which are completely free of charge for all citizens. The state reimburses the hospital for
the cost of each patient, and since reimbursement is dependent on correct coding, we assume
that this adds to the credibility of the data.
In general, registers in Statistics Denmark are considered to be valid sources of information
for epidemiological studies [17,29–32]. Another strength of this study is that a diagnosis of
CO-poisoning is simple and therefore limits misclassification. Usually, an arterial blood sam-
ple is analyzed for HbCO, and levels above 3% indicate intoxication (7–9% for smokers) [33].
A total of 40.0% of the patients who died from CO-poisoning since 2002 and underwent
autopsy, making the cause of death for this group even more accurate.
Carbon monoxide poisoning in Denmark
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In the present study, we decided to split patients into four age groups, aware that group
four would contain patients of a broad range of ages ranging from 55–85 years of age and that
patients of higher age may fare differently from younger patients. However, the number of
patients in the highest age range was relatively low.A major limitation of this study is the
absence of clinical information, especially regarding the severity of CO-poisoning which may
have caused some degree of residual confounding in our model.
Different propensity score techniques may be used to estimate treatment effects in observa-
tional studies trying to eliminate the impact of observed baseline covariates such as e.g. treat-
ment-selection bias. Inferences about treatment effect using propensity-score matching are
only valid if, in the matched sample, treated and untreated subjects have similar distributions
of measured baseline potentially confounding factors i.e. covariates. As we do not believe that
we would be able to balance measured covariates adequately, we did not apply any propensity
score models in the present study in addition to the statistical methods described. Further-
more, causal claims based on propensity score models rely on an assumption, that there are no
unmeasured confounders once we condition on the measured covariates. Hidden treatment-
selection bias cannot be excluded in the present study.
Furthermore, a diagnosis of CO-poisoning has not been validated in the DNPR. However,
we have no reason to believe that this diagnosis in the registry should be less valid than other
diagnoses, which have been proven to be valuable for epidemiological research [17,29–32].
Additionally, residual confounding of unmeasured and unknown data cannot be excluded.
Conclusions
Poisoning from smoke and/or CO is a frequent occurrence in Denmark, accounting for
numerous contacts with hospitals and numerous deaths every year. Suicide and suicide
attempts contribute heavily to these numbers. Both intoxication and mortality are highly asso-
ciated with co-morbidities, especially conditions that might interfere with cognitive and physi-
cal function. Treatment with HBO is not associated with an effect on short-term or long-term
survival after adjusting for CO-morbidities and age.
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